Sequoia Financial Advisors’s Axsome Therapeutics AXSM Stock Holding History

Sequoia Financial Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$217K	Buy	+887	New	+$192K	﹤0.01%	1926

Other funds holding AXSM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BWP

Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

TAM

Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return

Sequoia Financial Advisors's AXSM Position: Q2 2026 in Review

Sequoia Financial Advisors opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 887 shares worth $217K. The stake represents ﹤0.01% of the portfolio and ranks #1926 among its holdings.

47 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

Sequoia Financial Advisors held 887 shares of Axsome Therapeutics worth $217K as of Q2 2026.
Axsome Therapeutics was a new Sequoia Financial Advisors position in Q2 2026.
Axsome Therapeutics made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #1926 holding.
47 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.